Inscripta is developing cost-effective, sustainable solutions for a variety of biomanufacturing applications including agriculture, chemicals, feed, food, personal care, and pharmaceuticals.

Inscripta uses a proprietary next-generation microbial strain engineering platform, GenoScaler®, that is based on ultra-high-throughput CRISPR+ technologies and the principles of directed evolution, to manufacture and supply ingredients at scale. GenoScaler® allows unprecedented speed, efficiency, and low development costs to substantially de-risk the
process of developing biobased solutions. Founded in 2015, Inscripta is headquartered in Pleasanton, CA. For more information, visit www.Inscripta.com.